je.st
news
Tag: biotech
Favorite Biotech Picks - Cramer's Lightning Round
2015-11-18 14:17:45| Biotech - Topix.net
Gilead Sciences, Regeneron, Celgene, Biogen, Pfizer, Eli Lilly and Bristol-Myers are Cramer's top bullish picks in the biotech space. Skechers : The stock has been crushed but it's still up 37% for the year.
Tags: favorite
round
picks
biotech
Impact of Nautilus on Biotech and Pharmaceutical Patents
2015-11-16 21:13:08| Biotech - Topix.net
In Nautilus, Inc. v. Biosig Instruments, Inc. , 134 S. Ct. 2120 , the Supreme Court rejected the Federal Circuit's "insolubly ambiguous" standard for determining whether a patent claim meets the definiteness requirement under 35 U.S.C. 112, 2, and held that "a patent is invalid for indefiniteness if its claims, read in light of the specification delineating the patent, and the prosecution history, fail to inform, with reasonable certainty, those skilled in the art about the scope of the invention."
Tags: impact
patents
pharmaceutical
biotech
Clovis Blowup Conjures Bad Biotech Memories of ImClone Darkness
2015-11-16 20:08:16| Biotech - Topix.net
As with Imclone, the Clovis mess could have a long-lasting, negative effect on the entire biotech sector. For those too young to remember, ImClone, in 2001, was cruising towards FDA approval of its targeted colon cancer drug Erbitux.
Tags: bad
memories
darkness
biotech
Biotech Weekly: Stories To Track Into SABCS, Oncothyreon And Puma Biotechnology
2015-11-16 19:03:27| Biotech - Topix.net
After discussing Celsion Corporation in my first Stories To Watch Into SABCS, I will discuss upcoming data at SABCS for Oncothyreon and Puma Biotechnology in my second piece. I believe either notable ORR improvement for the ONT-380/T DM1 trial or continued display of promising efficacy trends in the brain metastases patient group could trigger a $5+pps for ONTY.
Tags: track
stories
weekly
biotech
Premarket Biotech Digest: Harvoni's Label Expansion, AstraZeneca's...
2015-11-16 15:58:38| Biotech - Topix.net
Click this link to find out how much you can save.) Last week, Gilead Sciences announced that its Harvoni has been approved by the FDA in new indications. The FDA approved the blockbuster drug for expanded use in patients with genotype 4, 5 and 6 chronic HCV infections and in patients co-infected with HIV.
Tags: label
expansion
digest
biotech
Sites : [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] next »